Low baseline HbA1c and reduced eGFR are associated with relatively unfavorable body recomposition after SGLT2 inhibitor therapy in type 2 diabetes
- DOI
- 10.3389/fendo.2026.1924744
- Published
- 2026-08-27
- Container
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fendo.2026.1924744,
title = {Low baseline HbA1c and reduced eGFR are associated with relatively unfavorable body recomposition after SGLT2 inhibitor therapy in type 2 diabetes},
author = {Mizuki Gobaru and Nao Hasuzawa and Noboru Kurinami and Nobuhiko Wada and Lixiang Wang and Ayako Nagayama and Kenji Ashida and Yoshinori Moriyama and Hideaki Jinnouchi and Masatoshi Nomura},
year = {2026},
journal = {Frontiers in Endocrinology},
doi = {10.3389/fendo.2026.1924744},
url = {https://doi.org/10.3389/fendo.2026.1924744}
}RIS
TY - JOUR TI - Low baseline HbA1c and reduced eGFR are associated with relatively unfavorable body recomposition after SGLT2 inhibitor therapy in type 2 diabetes AU - Mizuki Gobaru AU - Nao Hasuzawa AU - Noboru Kurinami AU - Nobuhiko Wada AU - Lixiang Wang AU - Ayako Nagayama AU - Kenji Ashida AU - Yoshinori Moriyama AU - Hideaki Jinnouchi AU - Masatoshi Nomura PY - 2026 JO - Frontiers in Endocrinology DO - 10.3389/fendo.2026.1924744 UR - https://doi.org/10.3389/fendo.2026.1924744 ER -
APA
Gobaru, M., Hasuzawa, N., Kurinami, N., Wada, N., Wang, L., Nagayama, A., Ashida, K., Moriyama, Y., Jinnouchi, H., & Nomura, M. (2026). Low baseline HbA1c and reduced eGFR are associated with relatively unfavorable body recomposition after SGLT2 inhibitor therapy in type 2 diabetes. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1924744
Source records
- crossref · retrieved 2026-09-27T07:49:11.480Z